The goal is not to replace physicians, but to transform fragmented evidence into faster, more consistent, and increasingly personalized decisions for people living with Crohn’s disease and ulcerative colitis. The review, published in the Chinese Medical Journal on June 9, 2026, examines how artificial intelligence is being developed across nearly every stage of IBD care. They then translate these observations into disease-activity scores, such as the Mayo Endoscopic Score for ulcerative colitis or the Simple Endoscopic Score for Crohn’s disease. For patients with Crohn’s disease, this noninvasive capability may be particularly valuable when disease is located beyond the reach of a colonoscope. Subject of Research: Artificial intelligence applications in inflammatory bowel disease careArticle Title: Artificial intelligence in inflammatory bowel disease: From current evidence, clinical translation, and the road to precision medicineNews Publication Date: June 9, 2026Web References: https://doi.org/10.1097/CM9.0000000000004170References: Chinese Medical Journal; DOI: 10.1097/CM9.0000000000004170Image Credits: www.ilmicrofono.it via OpenverseKeywords: artificial intelligence, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, precision medicine, endoscopy, histology, medical imaging, machine learning, digital health, multi-omics, clinical decision support